News|Videos|July 14, 2025

Your Opinion About Long-Acting PrEP: Fortune Effiong, Nigeria | IAS 2025

Author(s)Peter Wehrwein, Managing Editor

We asked people attending the International AIDS Society meeting in Kigali, Rwanda, their opinion about long-acting injectable HIV preexposure prophylaxis and what it could mean for HIV prevention. Fortune Effiong, a researcher at the University of Calabar Teaching Hospital in Nigeria, shared his views about the potential of self-injectable versions of PrEP.

Get the latest industry news, event updates and more from Managed Healthcare Executive.

Related to this article

November 4th, 2026

A Democratic Congress likely means more oversight for payers, not a Medicaid rollback

Democrats won Congress, but with Trump’s veto, their best healthcare tools are funding bills, hearings and bipartisan deals.

November 4th, 2026

A conversation with Jessica Castle, M.D., about the benefit of continuous glucose monitoring for type 2 diabetes patients not on insulin

In the CONNECT trial, CGM users with type 2 diabetes not on insulin saw larger A1C reductions and more time in range than those using finger-stick testing.

November 4th, 2026

The CVS Health split. How separate will the two companies really be?

CVS Health announced today that it is reorganizing into two publicly traded companies. The CEO spoke about working on "commercial agreements" between the two. Critics and competitors question how separate they will be.

November 4th, 2026

South Dakota voters reject Medicaid expansion trigger amendment

South Dakota voters rejected Amendment I, which could have ended Medicaid expansion for approximately 31,000 residents if federal funding fell below 90%.

November 4th, 2026

Christine Johnston on why Medicaid leads in biosimilar adoption

Christine Johnston says Medicaid plans have embraced biosimilars faster than commercial plans and challenges the idea that more expensive means better.

November 4th, 2026

Jeremy Gaskill on moving from Humana to Geisinger Health Plan

After more than 20 years at Humana, Jeremy Gaskill now leads nonprofit Geisinger Health Plan. The problems are the same, he says, the scale for solving them differs.

November 4th, 2026

On the advantages of health system-owned health plan, what Medicaid cuts might mean and the future of U.S. health insurance: A conversation with Geisinger's Jeremy Gaskill

Jeremy Gaskill took the reins at the Geisinger Health Plan earlier this year after a long career at Humana. He discusses the similarities and differences between Geisinger and Humana and the advantages of a health plan that is part of a health system.